All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Prevention of contrast agent-induced renal impairment in patients with chronic renal insufficiency and heart disease by high-dose intravenous N-acetylcysteine: a pilot study

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F06%3A00001350" target="_blank" >RIV/00023001:_____/06:00001350 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Prevention of contrast agent-induced renal impairment in patients with chronic renal insufficiency and heart disease by high-dose intravenous N-acetylcysteine: a pilot study

  • Original language description

    Contrast-induced nephropathy is a relatively common complication occurring after various procedures requiringiodisze contrast agent injection, especially in patients with pre-existing renal failure. Aim: This pilot study was designed to assess the effects of a high intravenous dose of N-acetylcysteine (NAC) on plasma creatinine concentration. Methods: Twenty patients with pre-existing renal insufficiency were given NAC at a dose of 100 mg/kg. No contrast agent was given to 10 patients (Group A), whereas10 patients received contrast at the time of coronary angiography (Group B). Changes in plasma creatinine were assessed at 3 hours and one day following NAC administration. Results: In Group B, NAC prevented creatinine increase: baseline levels were 210.98+/-77.33 ?mol/L, 200.26+/-71.94 ?mol/L (NS) after 3 hours, and 203.80+/-83.94 ?mol/L 24 hours later (NS). The following was seen in Group A patients: 201.21+/-42.28 ?mol/L, 190.31+/-42.74 ?mol/L (p<0.01), and 170.08+/-45.53 ?mol/L (p<0

  • Czech name

    Prevence poškození ledvin kontrastní látkou u pacientů chronickou renální nedostatečností a srdečním onemocněním nitrožilní aplikací vysokých dávek N-acetylcysteinu: pilotní studie

  • Czech description

    nefropatie indukovaná kontrastní látkou, pilotní studie

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2006

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Kardiologia Polska

  • ISSN

    0022-9032

  • e-ISSN

  • Volume of the periodical

    64

  • Issue of the periodical within the volume

    6

  • Country of publishing house

    PL - POLAND

  • Number of pages

    6

  • Pages from-to

    559-564

  • UT code for WoS article

  • EID of the result in the Scopus database